Noteworthy Wednesday Option Activity: CNK, PFE, VRAY
Stock Options Channel Staff - Wednesday, August 25, 3:32 PMAmong the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in Cinemark Holdings Inc (CNK), where a total of 34,056 contracts have traded so far, representing approximately 3.4 million underlying shares. That amounts to about 92.2% of CNK's average daily trading volume over the past month of 3.7 million shares. Especially high volume was seen for the $22.50 strike call option expiring September 17, 2021, with 11,414 contracts trading so far today, representing approximately 1.1 million underlying shares of CNK. Below is a chart showing CNK's trailing twelve month trading history, with the $22.50 strike highlighted in orange:
Pfizer Inc (PFE) options are showing a volume of 429,742 contracts thus far today. That number of contracts represents approximately 43.0 million underlying shares, working out to a sizeable 91.2% of PFE's average daily trading volume over the past month, of 47.1 million shares.
Particularly high volume was seen for the $48 strike call option expiring August 27, 2021, with 18,919 contracts trading so far today, representing approximately 1.9 million underlying shares of PFE. Below is a chart showing PFE's trailing twelve month trading history, with the $48 strike highlighted in orange:
And ViewRay Inc (VRAY) saw options trading volume of 12,088 contracts, representing approximately 1.2 million underlying shares or approximately 88.6% of VRAY's average daily trading volume over the past month, of 1.4 million shares.
Especially high volume was seen for the $6 strike call option expiring December 17, 2021, with 5,728 contracts trading so far today, representing approximately 572,800 underlying shares of VRAY. Below is a chart showing VRAY's trailing twelve month trading history, with the $6 strike highlighted in orange:
For the various different available expirations for CNK options, PFE options, or VRAY options, visit StockOptionsChannel.com.